Delivery Order SPE2DB24D2205-SPE2DB25FEDYG
Award Date
6/20/25
Potential Completion Date
6/23/25
Potential Value
$40K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,862.40, is for the delivery of GEMTESA 75 MG TABLET 90S, a prescription medication. The contract is a firm fixed-price, non-set-aside delivery order with a completion date of May 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price of $1,987.43 and a period of performance through June 16, 2025. The contract is not set aside and was awarded on June 15, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $31,102.17 and a period of performance through February 20, 2024. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,573.82, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a period of performance through June 18, 2025 and is a firm fixed-price contract. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,642.16, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 15, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of GEMTESA 75 MG TABLET 30S. The contract has a firm fixed price of $4,751.70 and a completion date of June 12, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a $28,189.69 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, with a period of performance through May 30, 2025. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as a global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,659.98, is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and is a firm fixed-price type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,139.87, is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance through June 28, 2024 and is a Firm Fixed Price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a $11,602.50 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of GEMTESA 75 MG TABLET 30S, with a completion date of June 5, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...